Acorda Therapeutics
ACOR
#11271
Rank
โ‚ฌ0.74 M
Marketcap
0,60ย โ‚ฌ
Share price
0.00%
Change (1 day)
-95.39%
Change (1 year)

EPS for Acorda Therapeutics (ACOR)

EPS in 2024 (TTM): -46,58ย โ‚ฌ

According to Acorda Therapeutics 's latest financial reports the company's current EPS (TTM) is -45,83ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -78,69ย โ‚ฌ an increase over its 2021 EPS that were of -181,84ย โ‚ฌ.

EPS history for Acorda Therapeutics from 2012 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-46,58ย โ‚ฌ
2022-78,69ย โ‚ฌ-56.72%
2021-181,84ย โ‚ฌ-16.13%
2020-216,82ย โ‚ฌ-65.51%
2019-628,59ย โ‚ฌ-898.61%
201878,71ย โ‚ฌ-114.88%
2017-529,11ย โ‚ฌ536.84%
2016-83,08ย โ‚ฌ-392.31%
201528,42ย โ‚ฌ-39.53%
201447,01ย โ‚ฌ4.88%
201344,82ย โ‚ฌ-89.54%
2012428,53ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sarepta Therapeutics
SRPT
-2,40ย โ‚ฌ-94.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-0,18ย โ‚ฌ-99.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-4,76ย โ‚ฌ-89.61%๐Ÿ‡ฉ๐Ÿ‡ช Germany
BioMarin Pharmaceutical
BMRN
-0,08199ย โ‚ฌ-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA